Skip to content
cisonews.net

Incident · 8-K Item 8.01; 8-K/A Item 1.05

Stryker cyberattack: what its SEC filings say about the March 2026 disruption

Compiled from public records. Updated 2026-11-16. By the cisonews.net Desk.

Stryker Corporation told the SEC on March 11, 2026 that it had identified a cybersecurity incident causing a global disruption to its Microsoft environment. In an amended filing dated April 9, 2026, it said the incident had a material impact on operations and on first-quarter 2026 financial results; the filings name no categories of personal information and give no count of affected people. Its first-quarter results, released on April 30, showed adjusted earnings per share down 8.5% to $2.60; by the second quarter, organic sales were up 9.0% and the company said it had made significant progress in recovering from the incident.

Entries like this one, in Wednesday’s docket

Wednesdays

Unsubscribe any time.

What happened and when

The original Item 8.01 filing reports that the company identified the incident on March 11, 2026. The company then started its response plan and an internal investigation with outside advisors.

An update to customers on March 12 described the operational picture. The same filing says the company did not believe patient-related services were disrupted or that connected products were affected.

How the description changed

The first filing said the company saw no sign of ransomware or malware. The March 23 filing revised that view after further work with outside experts. That filing also says the company had found no malicious activity aimed at its customers, suppliers, vendors or partners. It adds that website reports now describe disruption to the corporate network, beyond the Microsoft environment.

Effect on operations and finances

The April 9 amendment moved the disclosure under Item 1.05. The company lists the scope and duration of the disruption, the systems affected and possible customer and regulatory effects as factors in that decision. It does not expect a material effect on the full year. On recovery, it says manufacturing is fully operational and commercial systems are back. It plans to give more detail with first-quarter earnings on April 30, 2026.

What Stryker's quarterly reports said afterwards

Stryker's 10-Q for the first quarter of 2026, filed on May 11, 2026, says the incident disrupted its business operations and that it worked with third-party experts and law enforcement to contain it and restore operations. It says the investigation was still ongoing.

The same report says Stryker notified the applicable regulators and kept customers and vendors informed through several channels.

The cost shows up in the margin. Gross profit fell to 63.3% of net sales in the first quarter of 2026 from 63.8% a year earlier, which the company puts down to higher manufacturing and supply chain costs, mainly from idle production time during the incident. Idle production time is also one of the reasons it gives for lower operating margins in both of its segments, MedSurg and Neurotechnology and Orthopaedics.

The later reports carry the effect forward without a dollar figure:

ReportPeriodGross marginA year earlierWhat the report says about the incident
10-Q, filed May 11, 2026Three months to March 3163.3%63.8%Idle production time pushed manufacturing and supply chain costs up
10-Q, filed July 31, 2026Six months to June 3065.9%63.8%Tariff and inventory effects lifted the margin, partly offset by the first-quarter idle time
10-Q, filed October 30, 2026Nine months to September 3065.6%63.7%The same offset, still attributed to the first quarter

Outside the margin discussion, the second- and third-quarter reports mention the incident only in their forward-looking statements, as an uncertainty for operations and results.

What the earnings releases said

Stryker's quarterly results releases, filed with the SEC as exhibits to Form 8-K, show the quarter of the attack and the two after it. The first-quarter release, dated April 30, 2026, reported net sales up 2.6% to $6.0 billion, organic net sales up 2.4%, the adjusted operating income margin down 180 basis points to 21.1% and adjusted earnings per share down 8.5% to $2.60. In the same release, the chair and chief executive, Kevin A. Lobo, said: "I am pleased with our team's ability to recover quickly from the cyber incident and continue delivering for our customers and their patients." The company kept its full-year 2026 guidance of 8.0% to 9.5% organic sales growth and adjusted earnings per share of $14.90 to $15.10.

The second-quarter release, dated July 30, 2026, reported net sales up 9.4% to $6.6 billion, organic net sales up 9.0% and adjusted earnings per share up 17.9% to $3.69. Lobo said the company had "made significant progress in our recovery from the cyber incident". Guidance was narrowed to 8.3% to 9.3% organic growth and $14.95 to $15.10 adjusted earnings per share.

The third-quarter release, dated October 29, 2026, does not mention the incident in its results or its chief executive's comments. It reported organic net sales up 7.7% and lowered guidance to 6.5% to 7.0% organic growth and $14.80 to $14.90 adjusted earnings per share, without tying the change to the attack.

ReleaseQuarterNet salesOrganic growthAdjusted EPSFull-year guidance after the release (organic growth; adjusted EPS)The incident in the release
April 30, 2026Q1 (attack on March 11)$6.0 billion, +2.6%2.4%$2.60, −8.5%8.0% to 9.5%; $14.90 to $15.10 (kept)Says the team recovered quickly
July 30, 2026Q2$6.6 billion, +9.4%9.0%$3.69, +17.9%8.3% to 9.3%; $14.95 to $15.10 (narrowed)Says recovery made significant progress
October 29, 2026Q3$6.5 billion, +7.7%7.7%$3.52, +10.3%6.5% to 7.0%; $14.80 to $14.90 (lowered)Forward-looking statements only

Stryker cyber attack: common questions

What happened in the Stryker cyber attack?

On March 11, 2026, Stryker identified a cybersecurity incident that caused a global disruption to its Microsoft environment. It activated its response plan and brought in outside advisors and cybersecurity experts. Later website updates, quoted in its March 23 filing, widened that to the corporate network environment, including but not limited to the Microsoft environment.

Was the Stryker attack ransomware?

Stryker first said it had no indication of ransomware or malware. By March 23, working with Palo Alto Networks' Unit 42, it had found that the attacker used a malicious file to run commands and hide its activity. Stryker said that file could not spread inside or outside its environment. None of the filings uses the word ransomware for what was found, and none names the attacker.

Were patients or Stryker's medical devices affected?

On March 12, Stryker said it did not believe its patient-related services had been disrupted or its connected products affected. Order processing, manufacturing and shipping were disrupted. On March 23 it said the investigation had found no malicious activity aimed at its customers, suppliers, vendors or partners.

How long were Stryker's systems down?

The filings do not give a single restoration date. By its April 9 amendment, Stryker said it was fully operational across its global manufacturing network, and its commercial, ordering and distribution systems had been restored. That is 29 days after the incident was identified.

What did the attack cost Stryker?

The April 9 amendment says the incident had a material impact on operations and on first-quarter 2026 results. Stryker weighed the scope and length of the disruption, the systems affected and possible customer and regulatory effects. It also said the incident was not reasonably likely to have a material effect on its 2026 full-year guidance. The quarterly reports above tie a lower first-quarter gross margin to idle production time; none gives a dollar figure for the attack.

Did the cyber attack change Stryker's 2026 guidance?

Not at first. On April 30, 2026, after the quarter of the attack, Stryker kept its full-year guidance of 8.0% to 9.5% organic sales growth and $14.90 to $15.10 adjusted earnings per share, and its chief executive said the company remained committed to it. The guidance was narrowed in July and lowered in October; the October release does not link the cut to the incident.

Who was behind the Stryker cyber attack?

Stryker's filings do not name an attacker. The March 23 filing refers only to a threat actor and the malicious file it used, and none of the later 8-Ks, 10-Qs or results releases identifies a group.

What the documents leave open

The company states that its work continues. Neither the 8-Ks nor the three later 10-Qs say how the actor gained access, and none gives a dollar figure for the financial impact. They do not say whether any company, customer or third-party data was taken or released, and they do not describe notification letters to individuals. The forward-looking statements only list unauthorized release of data as a risk factor.

How this disclosure's timing compares

Stryker disclosed 0 days after the discovery date its filing gives. Across the 46 other filings under 8-K Item 1.05 on cisonews.net that date discovery to the day, the median gap is 6 days.

The rule behind an Item 1.05 filing

Form 8-K Item 1.05 is where a public company reports a cybersecurity incident it has determined to be material. Under the rule the SEC adopted on July 26, 2023, the filing is generally due four business days after the company determines that the incident is material. Source: U.S. Securities and Exchange Commission, press release 2023-139. The guide What is SEC Form 8-K Item 1.05, and what counts as a disclosed cyber incident? reads the rule in full, and the glossary defines Form 8-K Item 1.05.

Other life sciences & medical devices incidents on cisonews.net

All life sciences & medical devices incidents

Sources

  1. 2026-03-11 · AStryker Corporation, Form 8-K (SEC EDGAR), published March 11, 2026
  2. 2026-03-12 · AStryker Corporation, Form 8-K, Item 7.01 (SEC EDGAR), published March 12, 2026
  3. 2026-03-23 · AStryker Corporation, Form 8-K, Item 7.01 (SEC EDGAR), published March 23, 2026
  4. 2026-04-09 · AStryker Corporation, Form 8-K/A, Item 1.05 (SEC EDGAR), published April 9, 2026
  5. 2026-05-11 · AStryker Corporation, Form 10-Q for the quarter ended March 31, 2026 (SEC EDGAR), published May 11, 2026
  6. 2026-07-31 · AStryker Corporation, Form 10-Q for the quarter ended June 30, 2026 (SEC EDGAR), published July 31, 2026
  7. 2026-10-30 · AStryker Corporation, Form 10-Q for the quarter ended September 30, 2026 (SEC EDGAR), published October 30, 2026
  8. 2026-04-30 · AStryker Corporation, first quarter 2026 results, Form 8-K Exhibit 99.1 (SEC EDGAR), published April 30, 2026
  9. 2026-07-30 · AStryker Corporation, second quarter 2026 results, Form 8-K Exhibit 99.1 (SEC EDGAR), published July 30, 2026
  10. 2026-10-29 · AStryker Corporation, third quarter 2026 results, Form 8-K Exhibit 99.1 (SEC EDGAR), published October 29, 2026
  11. 2023-07-26 · AU.S. Securities and Exchange Commission, press release 2023-139, published July 26, 2023

Tier A: the organization itself (including notices it filed with a state attorney general), a regulator or SEC EDGAR. Tier B: established press. Each fact on this page carries its supporting passage in the page source.

Entries like this one, in Wednesday’s docket

Wednesdays

Unsubscribe any time.